Under the agreement, Halyard Health, spun off from Kimberly-Clark Corp. in 2014, will transfer ownership of the S&IP business including the Hayard Health brand and company’s current IT platform.
The acquisition is expected to add $1 billion in revenue and $80 million in annual operating profits, according to the Richmond Times Dispatch.
The deal, subject to regulatory approval, is expected to close in 2018.
“This is a significant step that will strengthen and diversify our business model with a market-leading portfolio of surgical and infection prevention products,” Owens & Minor Chairman, President and CEO P. Cody Phipps, told the Richmond Times Dispatch.
The acquisition comes as Owens & Minor attempts to offset weakened financial results caused by pricing pressures in the healthcare supply industry and a loss of a large contract with Oakland, Calif.-based Kaiser Permanente’s insurance arm.
More articles on transactions and valuations:
Rice Memorial board OKs partnership with CentraCare, ACMC Health
FTC argues for preliminary injunction to halt Sanford, Mid Dakota merger
Elliot, Southern New Hampshire Health combine to create Solution Health
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
